Submitted by Anonymous (not verified) on 6 October 2025 - 16:30
Human medicines European public assessment report (EPAR): Minjuvi, tafasitamab, Date of authorisation: 26/08/2021, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Minjuvi, tafasitamab, Date of authorisation: 26/08/2021, Revision: 7, Status: Authorised